Orion Market Research Report Biosimulation Market | Page 2

The technological advancement and innovation in Bio-Simulation products and applications enable to reduce
the number of clinical studies for drug development.
Browse the full report on Bio-Simulation Market, by Application (Drug Development, Drug Discovery, Other
Applications), by Product (Software, Services, External/Contract Services), by End Users (Biotechnology And
Pharmaceutical Companies, Drug Discovery And Drug Development Companies, Education Centers And
Research Institutes, Regulatory Authorities, Other) – Global Trends, Market Size, Share, Research and
Forecast to 2023 at: https://www.omrglobal.com/industry-reports/biosimulation-market/
Furthermore, the Global Bio-Simulation Market is segmented on the basis of product, application, and end-user.
The report provides detailed & insightful chapters which include market overview, key findings, strategic
recommendations, market estimations, market determinants, key company analysis, market insights, company
profiling, market segmentation, geographical analysis, analyst insights and predictive analysis of the market.
Market Segmentation
1. Global Bio-Simulation Market by Application
• Drug Development
• Drug Discovery
• Other Applications
2. Global Bio-Simulation Market by Product
• Software
• Services
• External/Contract Services
3. Global Bio-Simulation Market by End-User
• Biotechnology and Pharmaceutical Companies
• Drug Discovery and Drug Development Companies
• Education Centers and Research Institutes
• Regulatory Authorities
Regional Covered
•
•
•
•
North America (the US and Canada)
Europe (United Kingdom, Germany, France, Spain, and Italy)
Asia-Pacific (China, India, South Korea, and Japan)
Rest of the Word (the Middle East & Africa and Latin America)
Company Profiled
• Accelrys
• ACD/Labs